ArticleClinical and translational science2026

An Integrated Nonclinical and Clinical Risk Assessment of the Effects of Investigational ATRi Tuvusertib on QTc Interval in Patients With Solid Tumors.

Jatinder Kaur Mukker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.